FluoGuide intends to carry out a directed share issue of approximately SEK 25 million
Copenhagen, Denmark, 17:31 CEST, 10 March 2022 – FluoGuide A/S (publ), a developer of surgical precision solutions within oncology (“FluoGuide” or the “Company”) (Nasdaq First North Growth Market: FLUO) hereby announces its intention to carry out a directed share issue of approximately SEK 25 million to Swedish and international institutional investors (the “Directed Share Issue”). The Company has appointed ABG Sundal Collier to act as Sole Bookrunner (the “Bookrunner”) in connection with the Directed Share Issue.The subscription price and the total number of new shares in the Directed